Telangana CM Unveils 9 New Government Medical Colleges, with 8 More on the Horizon for 2024
IBPS RRB Office Assistants 2023: Prelims scorecard released; mains exam scheduled for September 16
SSC Delhi Police Constable Notification 2023 released; Apply for 7,547 vacancies
UKPSC RO ARO Recruitment Drive 2023: Registrations starts
RBI Recruitment Drive 2023: Apply for 450 assistant vacancies
Empowering Safety Measures: Himachal Pradesh Introduces 'School Safety' App for Disaster Management
Govt Mandates Study of 2 Indian Languages for Class 9-10 Students, 1 Language for Class 11-12
UPSC ESE Exam 2024: Registration begins for 167 posts
RRC CR Apprentice Recruitment 2023: Apply for 2,409 vacancies
Google Winter Internship 2024: A Gateway to Tech Excellence
Monday, Sep, 2023
Home / IIT Jodhpur Explores the Potential of Snake Venom in Combating Antibiotic Resistance
IIT Jodhpur Explores the Potential of Snake Venom in Combating Antibiotic Resistance
The innovation behind SP1V3_1 involves repurposing snake venom's natural antibacterial attributes. Researchers focused on retaining these valuable properties while eliminating the venom's toxic components, resulting in a safe and highly effective antimicrobial peptide.SP1V3_1 operates by utilizing a......
by Pragti Sharma / 18 Sep 2023 20:24 PM IST / 0 Comment(s) / 16
Image Courtesy : www.facebook.com/IITJOfficial
Researchers at the Indian Institute of Technology, Jodhpur (IIT Jodhpur), have achieved a significant breakthrough in the battle against antibiotic-resistant bacteria. They have developed a groundbreaking antimicrobial peptide named SP1V3_1, drawing inspiration from the potent antibacterial properties found in snake venom. This peptide exhibits remarkable capabilities in neutralizing gram-negative and gram-positive bacteria, offering a promising solution to the escalating problem of antibiotic resistance.
The innovation behind SP1V3_1 involves repurposing snake venom's natural antibacterial attributes. Researchers focused on retaining these valuable properties while eliminating the venom's toxic components, resulting in a safe and highly effective antimicrobial peptide.SP1V3_1 operates by utilizing a helical short peptide structure that enables it to efficiently penetrate bacterial cells, subsequently leading to their destruction. This approach not only circumvents bacterial resistance but also demonstrates versatility by effectively targeting a broad spectrum of bacteria. Key pathogens like E. coli, P. aeruginosa, K. pneumoniae, and MRSA are among the bacteria vulnerable to SP1V3_1's biocidal abilities.
The implications of this research are profound. SP1V3_1 not only offers a potential solution to antibiotic resistance but also presents itself as a versatile candidate within the medical community. Dr. Surajit Ghosh, the lead researcher, envisions a future where SP1V3_1 could be developed into a marketable pharmaceutical product following the necessary clinical trials. This could involve its use as an essential component in wound disinfection and healing ointments or as an injectable/oral drug for systemic administration.
This groundbreaking work has already taken significant steps towards recognition and implementation. It has been provisionally e-filed for patenting in India and has received grants from organizations such as SERB, India, and the SEED grant at IIT Jodhpur.
Beyond its current applications, SP1V3_1 holds the potential for further exploration. Its antimicrobial and immunomodulatory motif, FLPII, suggests that it may be investigated for antiprotozoal, antifungal, and even anticancer properties in future studies.
In summary, the development of SP1V3_1 is a remarkable achievement in the field of antimicrobials. It not only addresses a critical global health concern but also opens doors to a myriad of potential medical applications, marking a significant milestone in the fight against antibiotic resistance.